IOVANCE BIOTHERAPEUTICS INC IOV (0JDK.L) Financials

0JDK.L Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 852.3 million 178.3 million
2023-06-30 757.3 million 178.7 million
2023-03-31 824.8 million 157.9 million
2022-12-31 664.0 million 164.3 million

0JDK.L Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -87.7 million 15.8 million
2023-06-30 -103.5 million 16.7 million
2023-03-31 -105.5 million 15.7 million
2022-12-31 -80.7 million 19.5 million

0JDK.L Net Income

No data available :(

0JDK.L Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 361.4 million - -
2023-06-30 250.9 million - -
2023-03-31 626.3 million - -
2022-12-31 471.8 million - -

0JDK.L Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 245.8 million
2023-06-30 224.5 million
2023-03-31 213.7 million
2022-12-31 164.8 million

0JDK.L Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 3.6 million 87.5 million 27.0 million 5.9 million
2023-06-30 9.5 million 86.3 million - -
2023-03-31 5.7 million 82.7 million 28.1 million 5.7 million
2022-12-31 3.0 million 80.6 million 26.5 million 5.7 million

0JDK.L Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 469000 10.2 million
2023-06-30 238000 8.0 million
2023-03-31 - 5.7 million
2022-12-31 - 5.7 million

0JDK.L

Price: $10.30

52 week price:
3.22
18.31

Earnings Per Share: -2.30 USD

P/E Ratio: -3.97

Exchange: LSE

Sector: Healthcare

Industry: Pharmaceuticals, Biotechnology & Life Sciences

Market Capitalization: 18.7 million

Links: